07-Jan-2021

Global Glucosamine Market to Surpass US$ 1,091.2 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)--#AminoSugar--According to Coherent Market Insights, the global glucosamine market is estimated to be valued at US$ 763.7 million in 2020 and is expected to exhibit a CAGR of 5.2 % during the forecast period (2020-2027).

Key Trends and Analysis of the Global Glucosamine Market:

Key companies focusing on research and development on safety and efficacy of glucosamine for treatment of osteoarthritis is expected to propel growth of the global glucosamine market during the forecast period. For instance, in 2017, Vietstar Biomedical Research initiated an investigational clinical trial to study safety and efficacy of Polycan in combination with glucosamine for treatment of knee osteoarthritis.

Among regions, North America is expected to hold dominant position in the global glucosamine market during the forecast period owing to the increasing prevalence of arthritis in the region. The National Library of Medicine report published on September 2020 stated that in 2020 approximately 23% of all adults, or more than 54 million people, are suffering from arthritis in U.S.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4345

Key Market Takeaways:

The global glucosamine market is expected to exhibit a CAGR of 5.20% during the forecast period, owing to product launches in the glucosamine market. For instance, in 2019, Strides Consumer Private Limited, an India-based consumer health care company, launched Jointflex containing active ingredients such as glucosamine and chondroitin sulphate which is used for treatment of joint pain.

Competitive Landscape:

Key players operating in the global glucosamine market are Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI Health Sciences, Inc., Cargill, CellMark Chemicals, Andra Medi Pharma Pvt.Ltd, Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC), JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD. , Wellable Marine Biotech Holding Limited, Zhejiang Shinfuda Marine Biotechnology Corp, Spectrum Chemical Manufacturing Corporation and Atlina Life Sciences.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4345

Market Segmentation:

Global Glucosamine Market, By Product Type:
- Powder
- Tablets
- Capsules
- Liquid
Global Glucosamine Market, By Application:
- Rheumatoid Arthritis
- Asthma
- Inflammatory Bowel Disease
- Others
Global Glucosamine Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Glucosamine Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country:
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country/Region:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa

Related Market Intelligence Reports:

Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Asthma & COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators, Anticholinergics), Anti-Inflammatories (Inhaled Corticosteroids, Anti-Leukotriene, Monoclonal Antibodies), Combination Therapies), By Disease Type (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), and By Region (North America, Latin America, Europe Asia, Pacific Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Editor Details

Company:
- Businesswire

Last Updated: 07-Jan-2021